Tandem Diabetes Care Inc (TNDM) volume exceeds 1.91 million: A new investment opportunity for investors

A new trading day began on Tuesday, with Tandem Diabetes Care Inc (NASDAQ: TNDM) stock price up 3.48% from the previous day of trading, before settling in for the closing price of $22.73. TNDM’s price has ranged from $15.75 to $53.69 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 22.33%. Meanwhile, its annual earnings per share averaged 6.85%. With a float of $66.05 million, this company’s outstanding shares have now reached $66.57 million.

The extent of productivity of a business whose workforce counts for 2650 workers is very important to gauge. In terms of profitability, gross margin is 46.57%, operating margin of -16.18%, and the pretax margin is -15.82%.

Tandem Diabetes Care Inc (TNDM) Insider Updates

As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Tandem Diabetes Care Inc is 0.83%, while institutional ownership is 111.98%. The most recent insider transaction that took place on Mar 07 ’25, was worth 190,966. In this transaction EVP & Chief Operating Officer of this company bought 10,538 shares at a rate of $18.12, taking the stock ownership to the 10,538 shares. Before that another transaction happened on Nov 21 ’24, when Company’s Director sold 30,000 for $31.38, making the entire transaction worth $941,400. This insider now owns 165,190 shares in total.

Tandem Diabetes Care Inc (TNDM) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 6.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 67.20% during the next five years compared to -28.23% drop over the previous five years of trading.

Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators

Here are Tandem Diabetes Care Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.59.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -0.65 in one year’s time.

Technical Analysis of Tandem Diabetes Care Inc (TNDM)

The latest stats from [Tandem Diabetes Care Inc, TNDM] show that its last 5-days average volume of 1.31 million was inferior to 1.57 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 65.11%. Additionally, its Average True Range was 1.06.

During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 34.49%, which indicates a significant decrease from 91.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.52% in the past 14 days, which was lower than the 86.43% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $19.39, while its 200-day Moving Average is $31.74. Now, the first resistance to watch is $24.00. This is followed by the second major resistance level at $24.47. The third major resistance level sits at $25.22. If the price goes on to break the first support level at $22.78, it is likely to go to the next support level at $22.03. Assuming the price breaks the second support level, the third support level stands at $21.56.

Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats

With a market capitalization of 1.57 billion, the company has a total of 66,607K Shares Outstanding. Currently, annual sales are 940,200 K while annual income is -96,030 K. The company’s previous quarter sales were 234,420 K while its latest quarter income was -130,560 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.